Baekeland II Fund, the investment fund of Ghent University backs the Belgium-based instrumentation company.

Capital-E Partners, which has "an entrenched relationship" with IMEC, the micro and nano-electronic research centre, and Baekeland II Fund, the investment fund of Ghent University, have helped Belgian-based instrumentation company Trinean raise €2.7m ($3.5m). The company also appointed Philippe Stas to succeed Marc Zabeau as chief executive.

The first close of the round also included venture firms Vesalius Biocapital,  and Fidimec, the daughter company of Imec.

Stas was previously chief executive of Algonomics, a Belgium-based biotech service provider.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?